Saudi Arabia: Medical and Donor Requirements for Assisted Reproduction
The short answer: what Saudi law permits
Saudi Arabia’s statutory framework for assisted reproduction is restrictive. Treatment is not simply a matter of a clinic accepting a patient: the law ties fertilization procedures to medically supported infertility treatment within an existing marriage, and it restricts whose sperm and eggs may be used and where an embryo may be implanted. The reviewed legislation does not authorize third-party sperm or egg donation for the treatment covered by the statute, and it expressly bars implanting a married couple’s fertilized egg in another woman’s womb. These are legal boundaries, not optional clinic preferences. Meeting them does not guarantee that a clinic will offer treatment; a medical assessment, informed consent, a properly licensed unit and the applicable implementing rules still matter.
Which sources control, and what this guide does not assume
The main source is Saudi Arabia’s Law of Fertilization, Utero-Fetal and Infertility Treatment Units, Royal Decree No. M/76, listed as in force in the Bureau of Experts’ official legal database. The Ministry of Health also publishes implementing regulations and an amendment to those regulations. This is a focused reading of the identified texts, not a claim that every ministry circular, professional standard or later amendment has been exhaustively checked. If a clinic relies on a newer circular, a particular supervisory-committee decision or a special written fatwa, obtain the document and confirm its legal effect before relying on it.
Medical indication: treatment must be supported by a medical report
Article 2 permits medical intervention to treat infertility resulting from low fertility or a treatable disease, on the basis of a medical report. It states that fertilization procedures must not be performed to treat infertility established to be incurable. The implementing regulations further refer to medical reports from Ministry-licensed units or centres that document the diagnosis, the person’s ability to reproduce and the medical permissibility of the intervention. In practical terms, a patient should expect a clinical assessment and a reasoned medical record, rather than assuming that a desired procedure is automatically available.
Article 1 of the Law defines infertility as the inability to conceive after 12 months of unprotected sexual intercourse within an existing marital relationship. Read this definition together with the required medical report and the individual clinical assessment.
A subsisting marriage is a legal precondition
Before treatment begins, the unit must establish that a marriage is currently in force. The implementing regulations require documentary proof of the subsisting marriage before treatment and require the unit to keep a copy in the case file. This is a legal eligibility condition, not merely a clinic’s preference about family status. A patient should ask in advance which original or certified marriage documents, identity records and translations the unit will accept, particularly where documents were issued abroad.
The statute also addresses divorce and the husband’s death: fertilization must stop when the marital relationship has ended through divorce or death. The implementing regulations contain a narrow provision referring to a written fatwa from the Council of Senior Scholars in the event of the husband’s death. Because the regulation and the statute must be read together, do not treat this wording as a general exception or proceed on a clinic’s oral assurance. No comparable exception is stated for divorce or a dispute between spouses. Obtain current Saudi legal advice and the actual written instrument before relying on any claimed exception.
Gametes: third-party sperm and egg donation are not permitted
Article 5 says that insemination must not use sperm from a man other than the husband and that an egg other than the wife’s must not be fertilized. For treatment under this law, that excludes donor sperm and donor oocytes from a third party. The legal framework is based on the husband’s sperm and the wife’s egg, subject to the medical and procedural requirements that otherwise apply. A donor’s consent, payment arrangement, anonymity agreement or clinic consent form cannot by itself override this statutory restriction.
Ask the unit to confirm in writing whose sperm and oocytes will be used and how each sample is identified and tracked. Article 5 directly excludes donor sperm and donor eggs, and separately prohibits implanting a fertilized egg from one couple in another wife’s or woman’s womb; a donor embryo is therefore not a workaround. If the couple’s own gametes are stored at a bank or another clinic, the storage location alone does not make them third-party gametes, but ask the unit to verify ownership, identity and traceability before transfer or treatment. Separate rules for research samples do not authorize donor gametes for fertility treatment.
A gestational carrier or surrogate arrangement is barred by the statute
Article 5 also prohibits implanting a fertilized egg belonging to a married couple in the womb of another wife or another woman. That language directly rules out transferring the couple’s embryo to a gestational carrier under the assisted-reproduction regime covered by this law. The prohibition does not depend on whether the other woman is a relative, whether she receives payment, or whether all adults sign a private agreement. A contract or clinic marketing statement cannot make a prohibited transfer lawful. This guide addresses the medical and gamete rules only; it does not determine parentage, birth registration, nationality, immigration or recognition of a foreign arrangement.
Written informed consent and clear cost information
Article 6 requires explicit written consent from both spouses to the treatment method after they have been informed about the procedures, risks and possible outcomes. The implementing regulations add that the physician must explain the procedures and risks, communicate the probability or percentage of success or failure, provide information booklets for the treatment stages, and inform the spouses of the total cost before treatment starts. Consent should therefore be specific and informed, not a blanket signature obtained before the treatment plan is explained.
Before signing, request a copy of the treatment plan, the consent form in a language you understand, the clinic’s explanation of likely outcomes and material risks, and the full expected cost. Ask how consent can be withdrawn and what happens to any stored reproductive material if treatment stops; confirm the answer against the applicable regulations and the signed documents.
Identity checks, traceability and the embryo-transfer limit
The law requires at least two specialists in the unit to verify that both spouses’ identities and medical-record numbers match when samples are collected, fertilization is carried out, and embryos or zygotes are transferred. The implementing regulations require systems and documented checks designed to prevent sperm, eggs and embryos from being mixed up or substituted, whether accidentally or deliberately. Ask how the clinic labels, verifies, records, stores and transfers samples, and what incident-reporting process applies if an error is suspected.
The implementing regulations state that no more than three embryos or zygotes may be returned to the wife’s womb in one course of IVF or ICSI treatment. This is a ceiling in the text, not a recommendation to transfer three; the appropriate number in an individual case is a separate medical decision within the applicable rules. Ask the treating specialist to explain the planned number, the medical reasoning and the risks. A clinic’s general brochure should not replace a patient-specific explanation.
Genetic interventions require a narrow basis and prior approval
Article 8 prohibits intervention in sex cells or genetic material except for treating hereditary or genetic diseases that may affect the embryo and can be treated through gene therapy, provided the Supervisory Committee approves the intervention in advance. The implementing regulations further describe prohibited interventions involving reproductive cells or organs and changes to genetic characteristics, and state that the exception is tied to treatment of a qualifying disease and prior approval. This is not a general authorization for elective genetic selection, enhancement or any test marketed as “genetic treatment.”
If a clinic proposes a genetic procedure, request the precise medical indication, the legal provision relied on, the committee’s written prior approval and the scope of that approval. Do not infer approval from a clinician’s recommendation, a laboratory’s ability to perform a test, or the fact that a procedure is offered abroad. The legal exception is narrow; a Saudi-qualified reviewer should confirm that the specific proposed procedure falls within it.
Medical tests: separate the statute from clinical protocol
The cited statutory provisions establish eligibility and safety principles, but they do not themselves provide a complete, universal list of pre-treatment tests for every intended parent. A clinic may require blood tests, infection screening, genetic assessment, imaging, semen analysis or other examinations according to the patient’s circumstances, the proposed technique and applicable professional standards. The existence and details of those requirements should be documented by the clinic; this article does not claim that any particular panel is mandatory nationwide unless an applicable rule is identified.
Ask the clinic for a written schedule with four columns: test or assessment; clinical reason; whether it is required by a specific law, regulation or official directive; and whether it is a clinic protocol. Ask who reviews the results, how long results remain valid, what happens if a result is abnormal, and whether a test can be repeated elsewhere. A clinic may apply medically justified operational criteria, but its own policy must not be presented as Saudi statutory text or used to bypass the legal restrictions on marriage, gamete origin or embryo placement.
Documents to prepare before the first appointment
The following is a practical preparation list, not a claim that every item is expressly named as a statutory document in every case. Confirm the clinic’s current checklist before arranging translations or paying for tests.
| Document | What to confirm |
|---|---|
| Marriage evidence | Documents proving a subsisting marriage; ask whether originals, certified copies, authentication or Arabic translation are required. |
| Identity records | Identity documents for both spouses, matching the names and medical-record details that the unit will use. |
| Medical evidence | Relevant history, prior investigations and reports from licensed medical providers that support the diagnosis and proposed treatment. |
| Consent and cost | The proposed treatment method, written consent, risk/outcome explanation, treatment-stage information and total-cost statement. |
| Clinic status | The unit’s Ministry of Health licence and licensed activity level; confirm that the proposed technique is within that level. |
Use a properly licensed fertility unit
Articles 19 and 20 require a fertility, embryo and infertility-treatment unit to obtain a Ministry of Health licence and operate within its licensed level. The statutory framework distinguishes levels of activity, including ovulation-induction treatment, artificial insemination, and IVF/ICSI with micromanipulation. A licence for one level should not be assumed to authorize every technique. Before treatment, ask for the unit’s current licence, the level shown on it, the responsible medical supervisor’s credentials and confirmation that the planned procedure is covered.
The reviewed official sources establish the licensing requirement, but they do not verify that any named clinic currently holds a valid licence. This guide therefore does not endorse or certify a provider. Check the actual licence and current Ministry records directly, and keep a copy of the document or official confirmation. If the unit will not identify its licence or will not explain the permitted level of activity, do not rely solely on advertising, a broker’s assurance or a social-media post.
Consequences of serious violations
Article 32 lists certain serious violations, including performing fertility treatment without a licence or outside the licensed level, using sperm or embryos in a woman other than the wife, carrying out the procedure after the marital relationship has ended, transferring a couple’s embryo to another woman’s womb, and genetic intervention without prior Supervisory Committee approval. For the listed violations, the law provides for one or more penalties: a fine of SAR 200,000 to SAR 500,000, imprisonment for up to five years, and cancellation of the professional licence, without prejudice to any more severe penalty under another law.
These sanctions should not be read as an automatic prediction for every factual situation. Classification, proof, the applicable provision and any other relevant law matter. Other violations may fall under different provisions and penalties. If a clinic proposes a procedure that appears inconsistent with the statute, preserve written communications and documents and seek advice from a Saudi-qualified lawyer before proceeding. Do not rely on a broker’s claim that a private contract eliminates regulatory exposure.
A safer decision sequence
1. Define the proposed technique and the medical reason for it. Ask the treating physician to state the diagnosis and explain how the medical report supports treatment under Article 2. 2. Confirm the marriage requirement and ask the unit which documents prove that the marriage is currently in force. 3. Confirm the source of every sperm and egg sample and where the embryo would be implanted. If the plan involves donor sperm, donor eggs, a donor embryo, or implantation in another woman’s womb, stop before paying and obtain independent advice from a Saudi-qualified lawyer.
4. Verify the unit’s Ministry licence and the licensed activity level against the planned technique. 5. Obtain the test schedule, itemized cost, treatment plan and written informed consent before treatment begins. 6. Ask about sample-identification safeguards, the proposed number of embryos and any genetic intervention. For a genetic procedure, request the legal basis and prior committee approval. 7. Keep copies of the medical report, marriage evidence, consent forms, cost estimate, licence confirmation, test results and correspondence. If a clinic’s answer conflicts with the statute or depends on an exception, request the cited rule and have it checked by a Saudi-qualified lawyer.
How the rules apply to common scenarios
A married couple using the husband’s sperm and the wife’s egg may still need a medical report supporting the intervention, proof of a subsisting marriage, written consent and treatment at a properly licensed unit. Meeting those baseline conditions does not establish that every procedure is medically appropriate or that the clinic must accept the case.
A plan to use donor sperm or donor eggs conflicts with Article 5’s own-gamete restrictions. A plan to transfer the couple’s embryo to a sister, relative or paid gestational carrier conflicts with Article 5’s separate prohibition on implantation in another woman’s womb. A clinic’s willingness to discuss either plan does not amend the law. A proposal for genetic intervention requires a qualifying disease-related purpose and prior committee approval; a general genetic-screening offer is not enough. If treatment is proposed after divorce or the husband’s death, do not proceed on assumptions: the statutory wording and the narrow reference to a written fatwa in the implementing regulations require specific legal review.
What remains open and the practical conclusion
Saudi law sets the legal restrictions described above, but it does not establish a complete nationwide test panel, a universal age limit, the current licence status of a named clinic, or the outcome of an individual medical assessment. Those points must be confirmed from the current applicable rules, the clinic’s documented protocol and the patient’s facts. The guide reflects the law as of 23 October 2026; check for later directives or amendments before a real treatment decision. The practical rule is simple: establish medical indication and marital status, use only the spouses’ own gametes, do not plan embryo transfer to another woman, obtain informed written consent, and verify both the clinic licence and any claimed exception before treatment.
